Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 2003 Sep;79(935):522–526. doi: 10.1136/pmj.79.935.522

Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty

H Dai 1, J Chen 1, Q Tao 1, J Zhu 1, F Zhang 1, L Zheng 1, Y Qiu 1
PMCID: PMC1742832  PMID: 13679549

Abstract

Aims: To evaluate effects of diltiazem on platelet hyper-reactivity in situations associated with endothelial injury and their possible relationship to cytosolic calcium concentration.

Methods: Blood samples were collected at seven time points from 35 patients undergoing percutaneous transluminal coronary angioplasty (PTCA) who received combined diltiazem and aspirin/ticlopidine therapy or aspirin/ticlopidine therapy alone. Platelet expression of glycoprotein IIb/IIIa and P-selectin, production of thromboxane B2, and cytosolic calcium concentration were measured, respectively, by whole blood flow cytometry, radioimmunoassay, and fluorospectrophotometry. The effects of diltiazem of different concentrations on expression of glycoprotein IIb/IIIa and P-selectin were also studied in vitro in blood samples from patients with chronic stable angina.

Results: Of the two treatments, aspirin/ticlopidine therapy did not prevent an acute increase of expression of glycoprotein IIb/IIIa and P-selectin and plasma thromboxane B2 five minutes and 10 minutes after first inflation and 10 minutes after PTCA, whereas combined diltiazem and aspirin/ticlopidine therapy had a significant inhibitory effect. In the group receiving aspirin/ticlopidine therapy, there was a short term increase of platelet [Ca2+]i immediately after PTCA which was significantly reduced by diltiazem treatment. Expression of glycoprotein IIb/IIIa and P-selectin was significantly inhibited in vitro by diltiazem in the concentration of 200 ng/ml or higher, but not 50 ng/ml.

Conclusions: Combined diltiazem and aspirin/ticlopidine therapy significantly inhibited platelet activation that continued in the presence of conventional aspirin/ticlopidine treatment. Antiplatelet effects of diltiazem were probably a consequence of reduction of platelet [Ca2+]i and may only be achieved in higher than therapeutic concentrations.

Full Text

The Full Text of this article is available as a PDF (171.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fredrickson B. J., Turner N. A., Kleiman N. S., Graziadei N., Maresh K., Mascelli M. A., Effron M. B., McIntire L. V. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation. 2000 Mar 14;101(10):1122–1129. doi: 10.1161/01.cir.101.10.1122. [DOI] [PubMed] [Google Scholar]
  2. Gasperetti C. M., Gonias S. L., Gimple L. W., Powers E. R. Platelet activation during coronary angioplasty in humans. Circulation. 1993 Dec;88(6):2728–2734. doi: 10.1161/01.cir.88.6.2728. [DOI] [PubMed] [Google Scholar]
  3. Gregorini L., Marco J., Fajadet J., Bernies M., Cassagneau B., Brunel P., Bossi I. M., Mannucci P. M. Ticlopidine and aspirin pretreatment reduces coagulation and platelet activation during coronary dilation procedures. J Am Coll Cardiol. 1997 Jan;29(1):13–20. doi: 10.1016/s0735-1097(96)00428-7. [DOI] [PubMed] [Google Scholar]
  4. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  5. Hjemdahl P., Wallén N. H. Calcium antagonist treatment, sympathetic activity and platelet function. Eur Heart J. 1997 Jan;18 (Suppl A):A36–A50. doi: 10.1093/eurheartj/18.suppl_a.36. [DOI] [PubMed] [Google Scholar]
  6. Katopodis J. N., Kolodny L., Jy W., Horstman L. L., De Marchena E. J., Tao J. G., Haynes D. H., Ahn Y. S. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol. 1997 Feb;54(2):95–101. doi: 10.1002/(sici)1096-8652(199702)54:2<95::aid-ajh1>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  7. Knight C. J., Panesar M., Wilson D. J., Chronos N. A., Patel D., Fox K., Goodall A. H. Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. Circulation. 1997 Jan 7;95(1):125–132. doi: 10.1161/01.cir.95.1.125. [DOI] [PubMed] [Google Scholar]
  8. Koh H., Inoue A., Mashimo N., Numano F., Maezawa H. A radioimmunoassay of thromboxane B2 with thromboxane B2-125I-tyramide and its application to the study on the thromboxane B2 formation during platelet aggregation. Thromb Res. 1980 Feb 1;17(3-4):403–413. doi: 10.1016/0049-3848(80)90075-4. [DOI] [PubMed] [Google Scholar]
  9. Landau C., Lange R. A., Hillis L. D. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1994 Apr 7;330(14):981–993. doi: 10.1056/NEJM199404073301407. [DOI] [PubMed] [Google Scholar]
  10. Mehta J., Mehta P., Ostrowski N. Calcium blocker diltiazem inhibits platelet activation and stimulates vascular prostacyclin synthesis. Am J Med Sci. 1986 Jan;291(1):20–24. doi: 10.1097/00000441-198601000-00005. [DOI] [PubMed] [Google Scholar]
  11. Mizuno O., Hojo Y., Ikeda U., Katsuki T., Fukazawa H., Kurosaki K., Fujikawa H., Shimada K. Assessment of coagulation and platelet activation in coronary sinus blood induced by transcatheter coronary intervention for narrowing of the left anterior descending coronary artery. Am J Cardiol. 2000 Jan 15;85(2):154–160. doi: 10.1016/s0002-9149(99)00651-7. [DOI] [PubMed] [Google Scholar]
  12. Neumann F. J., Gawaz M., Dickfeld T., Wehinger A., Walter H., Blasini R., Schomig A. Antiplatelet effect of ticlopidine after coronary stenting. J Am Coll Cardiol. 1997 Jun;29(7):1515–1519. doi: 10.1016/s0735-1097(97)00073-9. [DOI] [PubMed] [Google Scholar]
  13. Oesterle S. N., Whitbourn R., Fitzgerald P. J., Yeung A. C., Stertzer S. H., Dake M. D., Yock P. G., Virmani R. The stent decade: 1987 to 1997. Stanford Stent Summit faculty. Am Heart J. 1998 Oct;136(4 Pt 1):578–599. doi: 10.1016/s0002-8703(98)70004-3. [DOI] [PubMed] [Google Scholar]
  14. Pannocchia A., Praloran N., Arduino C., Della Dora N., Bazzan M., Schinco P., Buraglio M., Pileri A., Tamponi G. Absence of (-) [3H]desmethoxyverapamil binding sites on human platelets and lack of evidence for voltage-dependent calcium channels. Eur J Pharmacol. 1987 Oct 6;142(1):83–91. doi: 10.1016/0014-2999(87)90656-x. [DOI] [PubMed] [Google Scholar]
  15. Putney J. W., Jr, Broad L. M., Braun F. J., Lievremont J. P., Bird G. S. Mechanisms of capacitative calcium entry. J Cell Sci. 2001 Jun;114(Pt 12):2223–2229. doi: 10.1242/jcs.114.12.2223. [DOI] [PubMed] [Google Scholar]
  16. Rink T. J. Cytosolic calcium in platelet activation. Experientia. 1988 Feb 15;44(2):97–100. doi: 10.1007/BF01952188. [DOI] [PubMed] [Google Scholar]
  17. Rink T. J., Sage S. O. Calcium signaling in human platelets. Annu Rev Physiol. 1990;52:431–449. doi: 10.1146/annurev.ph.52.030190.002243. [DOI] [PubMed] [Google Scholar]
  18. Rostagno C., Abbate R., Gensini G. F., Coppo M., Prisco D., Boddi M., Neri Serneri G. G. In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil. Thromb Res. 1991 Aug 15;63(4):457–462. doi: 10.1016/0049-3848(91)90232-l. [DOI] [PubMed] [Google Scholar]
  19. Rybak M. E., Renzulli L. A. Effect of calcium channel blockers on platelet GPIIb-IIIa as a calcium channel in liposomes: comparison with effects on the intact platelet. Thromb Haemost. 1992 Jan 23;67(1):131–136. [PubMed] [Google Scholar]
  20. Sanguigni V., Gallù M., Sciarra L., Del Principe D., Menichelli A., Palumbo G., Cannata D., Strano A. Effect of amlodipine on exercise-induced platelet activation in patients affected by chronic stable angina. Clin Cardiol. 1999 Sep;22(9):575–580. doi: 10.1002/clc.4960220907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shattil S. J., Cunningham M., Hoxie J. A. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987 Jul;70(1):307–315. [PubMed] [Google Scholar]
  22. Vaitkus P. T., Watkins M. W., Witmer W. T., Tracy R. P., Sobel B. E. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty. Coron Artery Dis. 1995 Jul;6(7):587–592. [PubMed] [Google Scholar]
  23. Walley T. J., Woods K. L., Barnett D. B. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting. Thromb Haemost. 1989 Feb 28;61(1):137–139. [PubMed] [Google Scholar]
  24. Zucker M. L., Budd S. E., Dollar L. E., Chernoff S. B., Altman R. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists. Thromb Haemost. 1993 Aug 2;70(2):332–335. [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES